Literature DB >> 3586125

The kinetics of triclabendazole disposition in sheep.

D R Hennessy, E Lacey, J W Steel, R K Prichard.   

Abstract

To investigate whether the disposition of triclabendazole (TCBZ) and its metabolites in blood or bile influenced its flukicidal potency, TCBZ was administered intraruminally at 10 mg kg-1 to sheep surgically fitted with a permanent re-entrant bile duct cannula. The profiles of TCBZ metabolites in peripheral plasma and bile were determined using high performance liquid chromatography. In plasma, only TCBZ sulphoxide (TCBZ-SO) and TCBZ sulphone were present and reached their maximum concentrations (greater than 13 micrograms ml-1) at 18 and 36 h, respectively, after administration. TCBZ metabolites were specifically bound to plasma albumin, which is believed to exert a major influence on the duration of plasma TCBZ metabolite concentrations and consequent exposure of liver fluke. In bile, the major TCBZ metabolites were hydroxylated in the 4' position and secreted predominantly as sulphate esters with lesser proportions as glucuronide conjugates. The major biliary metabolite was conjugated hydroxy TCBZ-SO which reached a maximum concentration in excess of 40 micrograms ml-1 and contributed almost half the total conjugated metabolites. The major free biliary metabolite was TCBZ-SO. Of the administered TCBZ dose, 9.7% was secreted as free metabolites in bile whereas 35.8% was secreted as conjugated metabolites. Approximately 6.5% of the dose was excreted in urine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3586125     DOI: 10.1111/j.1365-2885.1987.tb00078.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  22 in total

1.  Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes.

Authors:  M Meaney; I Fairweather; G P Brennan; L S L McDowell; A B Forbes
Journal:  Parasitol Res       Date:  2003-08-22       Impact factor: 2.289

2.  Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  Catherine Devine; Gerard P Brennan; Carlos E Lanusse; Luis I Alvarez; Alan Trudgett; Elizabeth Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2010-03-25       Impact factor: 2.289

3.  The efficacy and pharmacokinetics of long-term low-level intraruminal administration of triclabendazole in buffalo with induced fasciolosis.

Authors:  P K Sanyal; S C Gupta
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

4.  Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke.

Authors:  M Meaney; J Allister; B McKinstry; K McLaughlin; G P Brennan; A B Forbes; I Fairweather
Journal:  Parasitol Res       Date:  2006-08-02       Impact factor: 2.289

5.  Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  C Devine; G P Brennan; C E Lanusse; L I Alvarez; A Trudgett; E Hoey; I Fairweather
Journal:  Parasitol Res       Date:  2011-03-26       Impact factor: 2.289

6.  The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP.

Authors:  Borja Barrera; Jon A Otero; Estefanía Egido; Julio G Prieto; Anna Seelig; Ana I Álvarez; Gracia Merino
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

7.  Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.

Authors:  M Meaney; J Allister; B McKinstry; K McLaughlin; G P Brennan; A B Forbes; I Fairweather
Journal:  Parasitol Res       Date:  2006-12-19       Impact factor: 2.289

8.  The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

Authors:  Mark W Robinson; Jill Lawson; Alan Trudgett; Elizabeth M Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2003-12-03       Impact factor: 2.289

9.  Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.

Authors:  Laura Ceballos; Laura Moreno; Luis Alvarez; Laura Shaw; Ian Fairweather; Carlos Lanusse
Journal:  BMC Vet Res       Date:  2010-02-03       Impact factor: 2.741

10.  Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.

Authors:  N Mestorino; E A Formentini; M F Lucas; C Fernandez; P Modamio; E Mariño Hernández; J O Errecalde
Journal:  Vet Res Commun       Date:  2007-04-25       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.